Original Research

Published on 06 Sep 2022

A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Run Guo
Yuefei Zhou
Fang Lin
Mengxing Li
Chunting Tan
Bo Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.981604

3,368 views
2 citations

Original Research

Published on 02 Sep 2022

Development of a physiomimetic model of acute respiratory distress syndrome by using ECM hydrogels and organ-on-a-chip devices

in Respiratory Pharmacology

Esther Marhuenda
Alvaro Villarino
Maria Narciso
Linda Elowsson
Isaac Almendros
Gunilla Westergren-Thorsson
Ramon Farré
Núria Gavara
Jorge Otero

Frontiers in Pharmacology

doi 10.3389/fphar.2022.945134

3,838 views
12 citations

Original Research

Published on 31 Aug 2022

Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Måns Kadefors
Frida Berlin
Marie Wildt
Göran Dellgren
Sara Rolandsson Enes
Anders Aspberg
Gunilla Westergren-Thorsson

Frontiers in Pharmacology

doi 10.3389/fphar.2022.953771

2,607 views
1 citation

Case Report

Published on 29 Aug 2022

Case Report: Respiratory paralysis associated with polymyxin B therapy

in Respiratory Pharmacology

Yachan Ning
Yanqi Chu
You Wu
Ying Huang
Chunmei Wang
Li Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.963140

2,404 views
4 citations

Original Research

Published on 29 Aug 2022

Epithelial immunomodulation by aerosolized Toll-like receptor agonists prevents allergic inflammation in airway mucosa in mice

in Respiratory Pharmacology

David L. Goldblatt
Gabriella Valverde Ha
Shradha Wali
Vikram V. Kulkarni
Michael K. Longmire
Ana M. Jaramillo
Rosha P. Chittuluru
Adrienne Fouts
Margarita Martinez-Moczygemba
Jonathan T. Lei

Frontiers in Pharmacology

doi 10.3389/fphar.2022.833380

2,405 views
2 citations

Original Research

Published on 24 Aug 2022

Metformin suppresses proliferation and differentiation induced by BMP9 via AMPK signaling in human fetal lung fibroblast-1

in Respiratory Pharmacology

Qiongfeng Chen
Yaqun Wang
Linna Sheng
Yonghong Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.984730

2,305 views
1 citation

Original Research

Published on 19 Aug 2022

Acteoside attenuates RSV-induced lung injury by suppressing necroptosis and regulating metabolism

in Respiratory Pharmacology

Xiaoying Ling
Jie Zhou
Tianzi Jin
Weichen Xu
Xun Sun
Weifeng Li
Yali Ding
Miaomiao Liang
Chenbi Zhu
Peipei Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.870928

4,147 views
5 citations

Original Research

Published on 19 Aug 2022

Ruxolitinib inhibits cytokine production by human lung macrophages without impairing phagocytic ability

in Respiratory Pharmacology

Nikola Mantov
Mathilde Zrounba
Marion Brollo
S Grassin-Delyle
Matthieu Glorion
Mélanie David
Emmanuel Naline
Philippe Devillier
Hélène Salvator

Frontiers in Pharmacology

doi 10.3389/fphar.2022.896167

2,962 views
3 citations

Original Research

Published on 12 Aug 2022

Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population

in Respiratory Pharmacology

Tereza Hendrychova
Michal Svoboda
Josef Maly
Jiri Vlcek
Eva Zimcikova
Tomas Dvorak
Jaromir Zatloukal
Eva Volakova
Marek Plutinsky
Kristian Brat

Frontiers in Pharmacology

doi 10.3389/fphar.2022.860270

2,630 views
4 citations

Review

Published on 12 Aug 2022

Research progress and applications of nanobody in human infectious diseases

in Respiratory Pharmacology

Yaxian Mei
Yuanzhi Chen
Jwala P. Sivaccumar
Zhiqiang An
Ningshao Xia
Wenxin Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.963978

18,235 views
34 citations

Original Research

Published on 11 Aug 2022

Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

in Respiratory Pharmacology

Qinhai Ma
Ruihan Chen
Jing Zeng
Biao Lei
Feng Ye
Qihua Wu
Zhengtu Li
Yangqing Zhan
Bin Liu
Bojun Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.968182

4,037 views

Review

Published on 11 Aug 2022

Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis

in Respiratory Pharmacology

Yongfeng Yang
Hong Huang
Yi Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.928933

6,664 views
17 citations

Original Research

Published on 10 Aug 2022

Clinical Efficacy and In Vitro Drug Sensitivity Test Results of Azithromycin Combined With Other Antimicrobial Therapies in the Treatment of MDR P. aeruginosa Ventilator-Associated Pneumonia

in Respiratory Pharmacology

Yuqin Huang
Wenguo Wang
Qiang Huang
Zhengyan Wang
Zhuanzhuan Xu
Chaochao Tu
Dongli Wan
Miaobo He
Xiaoyi Yang
Huaqiang Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.944965

3,273 views
5 citations

Case Report

Published on 22 Jul 2022

Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A2 and Prostaglandin D2 Receptor Antagonist: A Four-Patient Case Series Report

in Respiratory Pharmacology

Martin L. Ogletree
Kate Chander Chiang
Rashmi Kulshrestha
Aditya Agarwal
Ashutosh Agarwal
Ajay Gupta

Frontiers in Pharmacology

doi 10.3389/fphar.2022.904020

3,389 views
9 citations

Original Research

Published on 22 Jul 2022

The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19

in Respiratory Pharmacology

Ping Jiang
Jingyao Ye
Menglong Jia
Xiaopeng Li
Shujun Wei
Nianhu Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.960267

3,630 views
9 citations

Review

Published on 21 Jul 2022

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis

in Respiratory Pharmacology

Hongbo Ma
Xuyi Wu
Yi Li
Yong Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2022.963054

15,449 views
44 citations

Navigation group

Articles

A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis

Development of a physiomimetic model of acute respiratory distress syndrome by using ECM hydrogels and organ-on-a-chip devices

Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis

Case Report: Respiratory paralysis associated with polymyxin B therapy

Epithelial immunomodulation by aerosolized Toll-like receptor agonists prevents allergic inflammation in airway mucosa in mice

Metformin suppresses proliferation and differentiation induced by BMP9 via AMPK signaling in human fetal lung fibroblast-1

Acteoside attenuates RSV-induced lung injury by suppressing necroptosis and regulating metabolism

Ruxolitinib inhibits cytokine production by human lung macrophages without impairing phagocytic ability

Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population

Research progress and applications of nanobody in human infectious diseases

Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis

Clinical Efficacy and In Vitro Drug Sensitivity Test Results of Azithromycin Combined With Other Antimicrobial Therapies in the Treatment of MDR P. aeruginosa Ventilator-Associated Pneumonia

Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A2 and Prostaglandin D2 Receptor Antagonist: A Four-Patient Case Series Report

The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis